Datasea Intelligent Technology Ltd. Announces CEO’s Intention to Purchase Up to US$1.0 Million of the Company’s Class A Ordinary Shares
BEIJING, June 16, 2026 /PRNewswire/ -- Datasea Intelligent Technology Ltd. (Nasdaq: DTSS) ("Datasea" or the "Company"), a technology company focused on acoustic high-tech and AI multimodal digital solutions, today announced that Ms. Zhixin Liu, the Company's Chief Executive Officer and a beneficial owner of approximately 32% of the Company's outstanding shares,...
Neurophet Showcases ‘Brain Imaging AI Solutions’ at BIO USA, Accelerates Global Business Development Collaborations
Introduces key products including an integrated brain imaging analysis solution for Alzheimer's disease treatment decision-making Expands partnering efforts with global pharmaceutical and biotech companies as well as potential customers, while introducing its ICL services SEOUL, South Korea, June 16, 2026 /PRNewswire/ -- Neurophet (Co-CEOs Jake Junkil Been and Donghyeon...
2026 Tang Prize in Biopharmaceutical Science Awarded to Three Pioneers of Cellular Immunotherapy
Revolutionizing Treatments for Blood Cancers and Solid Tumors TAIPEI, June 16, 2026 /PRNewswire/ -- On June 16, the Tang Prize in Biopharmaceutical Science announced its 2026 laureates. Three leading scientists in the field of cellular immunotherapy, Drs. Steven A. Rosenberg, Michel Sadelain, and Carl H. June, have been named joint laureates "for the discovery and development of tumor-infiltrating lymphocyte...
Crescom Launches Global PoC of Pediatric Musculoskeletal AI with Mass General Brigham
Mass General Brigham Department of Radiology Begins Clinical Validation and Utility of Three MediAI Pediatric Solutions BOSTON and SEOUL, South Korea, June 16, 2026 /PRNewswire/ -- Crescom (CEO Jae Joon Lee), a medical AI company specializing in musculoskeletal analysis, has officially launched a global clinical PoC of its pediatric musculoskeletal AI solutions in collaboration with the Department of Radiology...
Waterdrop Inc. Announces First Quarter 2026 Unaudited Financial Results
BEIJING, June 16, 2026 /PRNewswire/ -- Waterdrop Inc. ("Waterdrop", the "Company" or "we") (NYSE: WDH), a leading technology platform dedicated to insurance and healthcare services with a positive social impact, today announced its unaudited financial results for the three months ended March 31, 2026. Financial and Operational Highlights for the First Quarter of 2026 Strong Core Business...
Informa Markets and Thailand’s Health Ministry Join Forces To Deliver a Successful Edition of International Healthcare Week 2026 in Bangkok
BANGKOK, June 16, 2026 /PRNewswire/ -- Informa Markets joins forces with Thailand's Department of Health Service Support (DHSS) to unveil International Healthcare Week 2026, a transformative regional healthcare platform that will elevate Thailand's position as a world-leading medical and wellness hub and catalyze new waves of investment, innovation, and international partnerships across the healthcare industry. The event will take...
DIMERIX EXCLUSIVELY LICENSES DMX-200 IN GREATER CHINA, SOUTH KOREA AND SOUTHEAST ASIA TO EVEREST MEDICINES
Everest Medicines licenses exclusive rights to commercialise DMX-200 for the treatment of Focal Segmental Glomerulosclerosis (FSGS) in Greater China, South Korea and Southeast Asia 500,000-1 million people are estimated to be living with FSGS in the territories Dimerix eligible to receive upfront and potential success-based milestone payments of up to ~AU$481 million, plus royalties US$10 million...
Minghui Pharmaceutical Presents Compelling Phase I/II Results for MHB018A, a Novel Subcutaneous Anti-IGF-1R Antibody for Thyroid Eye Disease, in an Oral Presentation at ENDO 2026, the Endocrine Society’s Annual...
MHB018A demonstrated outstanding clinical activity in both active and chronic thyroid eye disease At 450 mg Q4W, MHB018A achieved a remarkable 81% proptosis response at Week 12 in active TED and a 76% proptosis response at Week 24 in chronic TED MHB018A was generally well tolerated among 98 treated patients, demonstrating an excellent safety profile, with all...
Frost & Sullivan Institute Celebrates Visionary Companies Addressing the World’s Most Pressing Challenges
SILICON VALLEY, Calif., June 16, 2026 /PRNewswire/ -- The Frost & Sullivan Institute is pleased to present the 2026 Visionary Growth Leadership Best Practices Recognition, celebrating leading enterprises that are redefining the role of business in addressing the world's most urgent challenges. This recognition honors organizations that have embedded innovation, measurable impact, and long-term sustainability into the core...
Revolutionizing Cancer Treatment: MAaGI Medical’s “i” Series Multimodal Tumor Therapy Technique Globally Debuted
SHANGHAI, June 15, 2026 /PRNewswire/ -- In the summer of Suzhou, a distinguished gathering of eminent professionals convened. From June 11 to 14, 2026, the 20th Annual Scientific Meeting of the Asia Pacific Society of Cardiovascular and Interventional Radiology (APSCVIR 2026) was ceremoniously held at the Suzhou International Expo Centre. The congress was presided over by Academician Gao-Jun Teng...
